Dietary Management for Mucopolysaccharidosis Type II (Hunter Syndrome)
There is no special or restrictive diet required for individuals with mucopolysaccharidosis type II (Hunter syndrome). Patients should follow a regular, balanced whole-food diet without specific carbohydrate, protein, or fat restrictions, as the disease mechanism involves enzyme deficiency rather than dietary substrate issues 1, 2, 3.
Core Dietary Principles
Patients with MPS II should consume a standard, nutrient-rich diet that emphasizes overall health rather than disease-specific restrictions. The primary treatment for MPS II is enzyme replacement therapy (ERT) with idursulfase, not dietary modification 1, 4, 5.
Recommended Dietary Pattern
- Follow a predominantly plant-based, nutrient-rich diet including vegetables, fruits, legumes, and whole grains, with vegetables and fruits comprising approximately half of each meal 1
- Consume fish 2-3 times per week, prioritizing oily fish such as salmon, sardines, or mackerel for omega-3 fatty acids and overall cardiovascular health 1
- Include lean protein sources such as poultry, fish, legumes, low-fat dairy, eggs, and nuts to support overall nutritional status 1
- Use extra virgin olive oil as the primary added fat for cooking and dressing 1
- Limit red meat consumption to no more than 18 ounces (cooked) per week 1
- Avoid processed meats such as bacon, hot dogs, deli cuts, and sausage 1
Foods to Minimize
- Limit processed foods high in fat, starches, or sugars including chips, cookies, candy bars, desserts, processed baked goods, sugary cereals, and fried foods 1
- Restrict sugar-sweetened beverages including sodas, fruit drinks, sports drinks, and sweetened iced teas 1
- Keep refined sugars below 6 teaspoons (25g) for a 2000-calorie diet or below 9 teaspoons (38g) for a 3000-calorie diet 1
Important Clinical Considerations
Why Diet Doesn't Alter Disease Progression
Unlike glycogen storage diseases or other metabolic conditions where dietary substrate restriction is therapeutic, MPS II results from deficiency of the lysosomal enzyme iduronate-2-sulfatase, leading to accumulation of glycosaminoglycans (dermatan and heparan sulfates) in tissues 1, 3. This accumulation occurs regardless of dietary intake, as these substances are produced endogenously through normal cellular metabolism 3, 6.
Nutritional Monitoring Requirements
Adult patients with MPS II require regular nutritional assessments as part of multidisciplinary care, particularly given the high surgical burden (47% undergo surgery in adulthood) and multisystem disease involvement 4, 5.
- Monitor calcium and vitamin D intake to support bone health, as patients may have reduced mobility and increased fracture risk 4
- Ensure adequate overall caloric intake to maintain healthy weight, particularly in patients with reduced physical activity due to joint disease 4, 5
- Assess swallowing function in patients with airway involvement or cognitive impairment, as dysphagia may require texture modifications 4, 6
Common Pitfalls to Avoid
Do not implement restrictive diets based on other mucopolysaccharidoses or lysosomal storage diseases, as each MPS type has distinct pathophysiology 1. The Specific Carbohydrate Diet, FODMAP diet, or other restrictive regimens have no role in MPS II management and may lead to unnecessary nutritional deficiencies 1.
Do not confuse MPS II dietary management with glycogen storage disease type III, which requires specific high-protein, complex carbohydrate diets with cornstarch supplementation 1. These conditions are fundamentally different in their metabolic derangements.
Avoid alcohol consumption or consume sparingly, as lower alcohol levels are associated with better overall health outcomes 1.
Practical Implementation
Patients should work with a registered dietitian for personalized guidance on achieving a balanced, nutrient-rich diet that supports overall health while accommodating any physical limitations from the disease 1.
Self-monitoring of food and beverage intake can be an effective strategy for weight management, particularly important given that approximately one-third of patients may develop obesity 1.
Ensure adequate hydration and regular meal timing (5-6 smaller meals throughout the day if needed) to support overall metabolic function 1.
Treatment Priority
The cornerstone of MPS II management is lifelong intravenous enzyme replacement therapy with idursulfase, not dietary intervention 1, 4, 5, 2. ERT has been shown to improve somatic signs and symptoms and increase life expectancy by approximately 12 years 4. Dietary recommendations serve only to support overall health and nutritional status in the context of multisystem disease, not to modify disease progression 5, 2, 6.